Plantar Fasciitis Treatment Market

Plantar Fasciitis Treatment Market (Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Plantar Fasciitis Treatment Market Outlook 2031

  • The global industry was valued at US$ 778.3 Mn in 2022
  • It is estimated to grow at a CAGR of 4.3% from 2023 to 2031 and reach US$ 1.1 Bn by the end of 2031

Analyst Viewpoint

Significant increase in obese population across the globe is a prominent factor that is fostering plantar fasciitis treatment market development. Treatment for plantar fasciitis, an inflammation of the fibrous tissue along the bottom of the foot that connects the heel bone to toes, ranges from icing to heel pain surgery.

Rise in patient preference for hospitalization as compared to OTC treatment is also boosting the plantar fasciitis treatment industry value.

Companies operating in the global plantar fasciitis treatment market are devising technologically advanced products for plantar fasciitis for sportspersons, as athletes are highly prone to plantar fasciitis.

Key manufacturers of plantar fasciitis treatment products are following the latest plantar fasciitis treatment industry trends and offering customized products such as bespoke orthotic insoles as per personal clinical specifications to increase their industry share.

Market Introduction

Plantar fasciitis is a common condition in which the plantar fascia, a thick fibrous ligament that supports the arch of the foot and connects the heel bone to the toe, becomes strained and inflamed, causing discomfort and heel pain.

Inflammation or damage to plantar fascia results in plantar fasciitis. Obese people and sportspersons are at greater risk of plantar fasciitis. As per a National Center for health Statistics (NCHS) report, one million people are likely to contract plantar fasciitis every year.

Orthotic insoles, shockwave therapy, and anti-inflammatory drugs are various options available to reduce pain caused due to planar fasciitis.Types of plantar fasciitis treatment include stretching and physical therapy, icing and medication, rest, activity modification, and orthotics, shockwave therapy, steroid injections, and gastrocnemius recession.

Attribute Detail
Market Drivers
  • Surge in Obese Population
  • Increase in Patient Preference for Hospitalization for Treatment

Surge in Obese Population Worldwide Fueling Plantar Fasciitis Treatment Market Growth

Rise in adoption of sedentary lifestyle, especially after the onset of the COVID-19 pandemic, is one of the key factors that has led to an increase in prevalence of obesity across the globe.

The obese population is more prone to ankle and joint inflammation, which may cause plantar fasciitis. Thus, rise in obese population worldwide is creating lucrative plantar fasciitis treatment market opportunities for companies operating in the sector.

According to OECD data published in 2022, obesity and other weight-related issues are widespread across the globe. These disorders are more prevalent in the U.S. due to excessive consumption of fast food, especially among the younger population, in the country.

As per the WHO, over 1 billion people across the world are obese. Healthcare personnel state that if the body mass index (BMI) is 30 or higher, the risk of contracting plantar fasciitis is six times higher.

Increase in Patient Preference for Hospitalization for Treatment

People suffering from plantar fasciitis are increasingly opting for hospitalization, as symptoms related to the disorder such as inflammation and pain can be closely monitored by the healthcare personnel and subsequent course of action can be decided upon with immediate effect.

Painkillers such as steroids or NSAIDs are often administered to patients during the course of the treatment for plantar fasciitis. Side-effects of these medications can be better addressed through continuous monitoring during hospitalization.

Surgery is recommended if chronic heel pain continues even after adoption of remedies such as orthotic arch supports, splints, taping of foot, strengthening and stretching exercises, anti-inflammatory medications, massage, platelet-rich plasma injections, radiofrequency ablation, and extracorporeal shock wave therapy.

Decisions regarding plantar fasciitis surgery can be taken promptly during the course of hospitalization.Thus, increase in preference for hospitalization among people suffering from plantar fasciitis across the globe is one of the primary plantar fasciitis treatment market drivers.

Regional Outlook

Attribute Detail
Leading Region North America

North America dominated the global plantar fasciitis treatment landscape in 2022. The region is expected to maintain its leading share during the forecast period.

The plantar fasciitis treatment market forecast appears promising in North America owing to the surge in incidence of obesity and availability of strong healthcare infrastructure in the U.S. and Canada.According to the latest plantar fasciitis treatment market analysis, Europe is projected to record steady industry progress in the near future.

As per NICE, 7% of the older and 4% of the general population in the U.K. suffers from plantar fasciitis. It further mentions that 8% to 10% of regular runners are afflicted with plantar fasciitis, which needs professional treatment.

Analysis of Key Players

As per the latest plantar fasciitis treatment market insights, companies operating in the global plantar fasciopathy treatment landscape are engaging in new product launches to cater to the growing population of individuals afflicted with plantar fasciitis. For instance, Ottobock has introduced the Malleo Immobil Night Splint that stretches the foot to facilitate nighttime healing.

Key players are investing substantially in research and development activities to introduce products that use a combination of extracorporeal shock therapy and local vibration for effective treatment of chronic plantar fasciitis.

Hanger, Inc., Bayer Group (Dr. Scholl’s), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc are some of the leading players operating in the global landscape.

The plantar fasciitis treatment market report highlights parameters such as company overview, business strategies, financial overview, product portfolio, and business segments of these companies.

Key Development

  • In June 2022, Atlecko introduced its 12-piece plantar fasciitis socks kit. These are scientifically designed compression socks that help relieve pain arising from plantar fasciitis.

Plantar Fasciitis Treatment Market Snapshot

Attribute Detail
Market Size in 2022 US$ 778.3 Mn
Market Forecast (Value) in 2031 US$ 1.1 Bn
Growth Rate (CAGR) 4.3%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Mn/Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Type
    • Medication Therapy
      • Oral
      • Parenteral
    • Shockwave Therapy
      • Extracorporeal Shock Wave Therapy (ESWT)
      • Intracorporeal Pneumatic Shockwave Therapy (IPST))
    • Surgery
    • Orthotics
    • Others
  • End-user
    • Hospitals
    • Clinics
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Hanger, Inc.
  • Bayer Group (Dr. Scholl’s)
  • A. Algeo Limited
  • Bauerfeind AG
  • Superfeet Worldwide, Inc.
  • Ottobock SE & Co. KGaA (Ottobock Holding)
  • Pfizer, Inc.
  • Sanofi
  • GlaxoSmithKline plc
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global plantar fasciitis treatment market in 2022?

It was valued at US$ 778.3 Mn in 2022

How is the plantar fasciitis treatment business expected to grow during the forecast period?

It is projected to grow at a CAGR of 4.3% from 2023 to 2031

What are the key factors driving the demand for plantar fasciitis treatment?

Rise in obese population worldwide and growth in patient preference for hospitalization for treatment

Which plantar fasciitis treatment end-user segment held the largest share in 2022?

The hospitals segment accounted for the largest share in 2022

Which region dominated the global plantar fasciitis treatment landscape in 2022?

North America was the dominant region in 2022

Who are the key plantar fasciitis treatment manufacturers?

Hanger, Inc., Bayer Group (Dr. Scholl’s), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Plantar Fasciitis Treatment Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Plantar Fasciitis Treatment Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Type, 2017–2031

        6.3.1. Medication Therapy

            6.3.1.1. Oral

            6.3.1.2. Parenteral

        6.3.2. Shockwave Therapy

            6.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

            6.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

        6.3.3. Surgery

        6.3.4. Orthotics

        6.3.5. Others

    6.4. Market Attractiveness Analysis, by Type

7. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. Hospitals

        7.3.2. Clinics

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region, 2017–2031

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Plantar Fasciitis Treatment Market Analysis and Forecast

    9.1. Introduction

    9.2. Key Findings

    9.3. Market Value Forecast, by Type, 2017–2031

        9.3.1. Medication Therapy

            9.3.1.1. Oral

            9.3.1.2. Parenteral

        9.3.2. Shockwave Therapy

            9.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

            9.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

        9.3.3. Surgery

        9.3.4. Orthotics

        9.3.5. Others

    9.4. Market Value Forecast, by End-user, 2017–2031

        9.4.1. Hospitals

        9.4.2. Clinics

        9.4.3. Others

    9.5. Market Value Forecast, by Country, 2017–2031

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. By Type

        9.6.2. By End-user

        9.6.3. By Country

10. Europe Plantar Fasciitis Treatment Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Type, 2017–2031

        10.3.1. Medication Therapy

            10.3.1.1. Oral

            10.3.1.2. Parenteral

        10.3.2. Shockwave Therapy

            10.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

            10.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

        10.3.3. Surgery

        10.3.4. Orthotics

        10.3.5. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Clinics

        10.4.3. Others

    10.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Italy

        10.5.5. Spain

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. By Type

        10.6.2. By End-user

        10.6.3. By Country/Sub-region

11. Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Type, 2017–2031

        11.3.1. Medication Therapy

            11.3.1.1. Oral

            11.3.1.2. Parenteral

        11.3.2. Shockwave Therapy

            11.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

            11.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

        11.3.3. Surgery

        11.3.4. Orthotics

        11.3.5. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Clinics

        11.4.3. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis

        11.6.1. By Type

        11.6.2. By End-user

        11.6.3. By Country/Sub-region

12. Latin America Plantar Fasciitis Treatment Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Type, 2017–2031

        12.3.1. Medication Therapy

            12.3.1.1. Oral

            12.3.1.2. Parenteral

        12.3.2. Shockwave Therapy

            12.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

            12.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

        12.3.3. Surgery

        12.3.4. Orthotics

        12.3.5. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Hospitals

        12.4.2. Clinics

        12.4.3. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Type

        12.6.2. By End-user

        12.6.3. By Country/Sub-region

13. Middle East & Africa Plantar Fasciitis Treatment Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Type, 2017–2031

        13.3.1. Medication Therapy

            13.3.1.1. Oral

            13.3.1.2. Parenteral

        13.3.2. Shockwave Therapy

            13.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

            13.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

        13.3.3. Surgery

        13.3.4. Orthotics

        13.3.5. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Clinics

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis

        13.6.1. By Type

        13.6.2. By End-user

        13.6.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    14.2. Market Share Analysis, by Company (2022)

    14.3. Company Profiles

        14.3.1. Hanger, Inc.

            14.3.1.1. Company Overview

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Financial Overview

            14.3.1.5. Strategic Overview

        14.3.2. Bayer Group (Dr. Scholl’s)

            14.3.2.1. Company Overview

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Financial Overview

            14.3.2.5. Strategic Overview

        14.3.3. A. Algeo Limited

            14.3.3.1. Company Overview

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Financial Overview

            14.3.3.5. Strategic Overview

        14.3.4. Bauerfeind AG

            14.3.4.1. Company Overview

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Financial Overview

            14.3.4.5. Strategic Overview

        14.3.5. Superfeet Worldwide, Inc.

            14.3.5.1. Company Overview

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Financial Overview

            14.3.5.5. Strategic Overview

        14.3.6. Ottobock SE & Co. KGaA (Ottobock Holding)

            14.3.6.1. Company Overview

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Financial Overview

            14.3.6.5. Strategic Overview

        14.3.7. Pfizer, Inc.

            14.3.7.1. Company Overview

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Financial Overview

            14.3.7.5. Strategic Overview

        14.3.8. Sanofi

            14.3.8.1. Company Overview

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Financial Overview

            14.3.8.5. Strategic Overview

        14.3.9. GlaxoSmithKline plc

            14.3.9.1. Company Overview

            14.3.9.2. Product Portfolio

            14.3.9.3. SWOT Analysis

            14.3.9.4. Financial Overview

            14.3.9.5. Strategic Overview

List of Tables

Table 01: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 02: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 05: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 08: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 11: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 14: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 17: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

List of Figures

Figure 01: Global Plantar Fasciitis Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by Type, 2022

Figure 03: Global Plantar Fasciitis Treatment Market Value Share, by Type, 2022

Figure 04: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by End-user, 2022

Figure 05: Global Plantar Fasciitis Treatment Market Value Share, by End-user, 2022

Figure 06: Global Plantar Fasciitis Treatment Market Value Share, by Region, 2022

Figure 07: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, 2023–2031

Figure 08: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

Figure 09: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

Figure 10: Global Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

Figure 11: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

Figure 12: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Region, 2022–2031

Figure 13: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Region, 2023–2031

Figure 14: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 15: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country, 2023–2031

Figure 16: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Country, 2022–2031

Figure 17: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

Figure 18: North America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

Figure 19: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

Figure 20: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

Figure 21: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 22: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 23: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 24: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

Figure 25: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

Figure 26: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

Figure 27: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

Figure 28: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 29: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 30: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 31: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

Figure 32: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

Figure 33: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

Figure 34: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

Figure 35: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 36: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 37: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 38: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

Figure 39: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

Figure 40: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

Figure 41: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

Figure 42: Middle East & Africa Plantar Fasciitis Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 43: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 44: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 45: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

Figure 46: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

Figure 47: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

Figure 48: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved